This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Haishan Zang: Innovator in Medicinal Chemistry
Introduction
Haishan Zang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit specific kinase activities. His work is crucial for advancing therapeutic options for various diseases.
Latest Patents
Haishan Zang holds a patent for a crystalline compound that acts as a c-Met kinase inhibitor. The patent, titled "Crystalline of compound as c-Met kinase inhibitor and preparation method therefor and use thereof," details a compound known as N-(4-((7-((1-(cyclopentylamino)cyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy)-3-fluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide. This invention focuses on the crystalline form of the compound, its preparation method, and its application in treating diseases linked to the inhibition of growth factor receptor protein tyrosine kinase activity. The crystalline exhibits excellent properties in pharmacokinetics, bioavailability, hygroscopicity, stability, solubility, purity, and ease of preparation.
Career Highlights
Throughout his career, Haishan Zang has demonstrated a commitment to innovation in medicinal chemistry. His research has led to advancements that could potentially improve treatment outcomes for patients suffering from conditions related to kinase activity.
Collaborations
Haishan Zang has collaborated with notable colleagues, including Feng Gong and Ticong Huang. Their combined expertise contributes to the success of their research endeavors.
Conclusion
Haishan Zang is a prominent figure in the field of medicinal chemistry, with a focus on developing innovative compounds for therapeutic use. His contributions, particularly in the area of c-Met kinase inhibition, highlight the importance of research in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile